413 related articles for article (PubMed ID: 19562258)
1. WHO grade II and III meningiomas: a study of prognostic factors.
Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
4. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognostic factors of WHO II and III adult spinal meningiomas: analysis of 25 cases in a single center.
Ye J; Lv G; Qian J; Zhu J; Han R; Luo C
J Neurooncol; 2016 Jun; 128(2):349-56. PubMed ID: 27056111
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
7. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
[TBL] [Abstract][Full Text] [Related]
8. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
9. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
11. Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas.
Winther TL; Torp SH
World Neurosurg; 2017 Mar; 99():104-110. PubMed ID: 27867123
[TBL] [Abstract][Full Text] [Related]
12. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Gousias K; Schramm J; Simon M
J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
[TBL] [Abstract][Full Text] [Related]
13. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
[TBL] [Abstract][Full Text] [Related]
14. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
17. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors.
Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D
Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920
[TBL] [Abstract][Full Text] [Related]
18. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Biczok A; Kraus T; Suchorska B; Terpolilli NA; Thorsteinsdottir J; Giese A; Tonn JC; Schichor C
J Neurooncol; 2018 Sep; 139(3):671-678. PubMed ID: 29808339
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.
Shan B; Zhang J; Song Y; Xu J
Medicine (Baltimore); 2017 Jun; 96(26):e7385. PubMed ID: 28658170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
